Blocking of EPHA2 either by ligand ephrinA1 or anti-EPHA2 antibodies reduced the infection in cancer organoids similar to that observed in cancer cell lines (Fig 5A, compare with Fig 1K), supporting a role for EPHA2 in EBV infection. The gene discussed is EPHA2; the disease is infection.